1. Lordick F, Ott K, Krause BJ, Weber WA, Becker K, Stein HJ, Lorenzen S, Schuster T, Wieder H, Herrmann K, Bredenkamp R, Höfler H, Fink U, Peschel C, Schwaiger M, Siewert JR (2007) PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 8:797–805
2. Tancini G, Bajetta E, Bonadonna G (1974) Bleomycin alone and in combination with methotrexate in the treatment of carcinoma of the esophagus. Tumori 60:65–71
3. Bonadonna G, De Lena M, Monfardini S, Bartoli C, Bajetta E, Beretta G, Fossati-Bellani F (1972) Clinical trials with bleomycin in lymphomas and in solid tumors. Eur J Cancer 8:205–215
4. Ravry M, Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ (1973) Treatment of advanced squamous cell carcinoma of the gastrointestinal tract with bleomycin (NSC-125066). Cancer Chemother Rep 57:493–495
5. Ezdinli EZ, Gelber R, Desai DV, Falkson G, Moertel CG, Hahn RG (1980) Chemotherapy of advanced esophageal carcinoma: Eastern Cooperative Oncology Group experience. Cancer 46:2149–2153